| NCT Number | NCT06992687 |
| Lead Sponsor | Shanghai Huaota Biopharmaceutical Co., Ltd.
Collaborators: Peking University Cancer Hospital & Institute, Zhejiang Cancer Hospital, Shandong Cancer Hospital and Institute, Hunan Cancer Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Second Affiliated Hospital of Harbin Medical University, Huazhong University of Science and Technology |
| Conditions | Solid Tumors |
| Enrollment | 30 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-09-30 (estimated) |
| Study Completion | 2025-11-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-05-28 |